| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/2014 | US20140030336 Pharmaceutical composition for the treatment of acute disorders |
| 01/30/2014 | US20140030333 Novel Pharmaceutical Preparation for Preeclampsia, Eclampsia, and Toxemia and Their Related Symptoms and Related Disorders of Pregnancy |
| 01/30/2014 | US20140030324 Compositions and methods for treating or preventing oxalate-related disease |
| 01/30/2014 | US20140030321 Solid pharmaceutical composition |
| 01/30/2014 | US20140030319 Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers |
| 01/30/2014 | US20140030317 Modulation of cell fates and activities by phthalazinediones |
| 01/30/2014 | US20140030313 Treatment of menstrual pain and excessive menstrual blood loss by intravaginal administration of a low dose of antifibrinolytic or hemostatic agent in combination with non-steroidal anti-inflammatory drug |
| 01/30/2014 | US20140030308 Implants and procedures for promoting autologous stem cell growth |
| 01/30/2014 | US20140030295 Use of Sirt1 Activators or Inhibitors to Modulate an Immune Response |
| 01/30/2014 | US20140030284 Compositions comprising chimeric ospa molecules and methods of use thereof |
| 01/30/2014 | US20140030278 Conjugates of tumor necrosis factor inhibitors to functionalized polymers |
| 01/30/2014 | US20140030274 Amyloidosis target useful in methods of treatment and for screening of compounds |
| 01/30/2014 | US20140030273 Human antibodies and antibody-drug conjugates against cd74 |
| 01/30/2014 | US20140030267 Compositions, methods and kits relating to resistin |
| 01/30/2014 | US20140030266 Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT |
| 01/30/2014 | US20140030251 Composition and method for reducing tissue damage from inflammatory disorder or pathogenic infection |
| 01/30/2014 | US20140030248 Injection paradigm for administration of botulinum toxins |
| 01/30/2014 | US20140030247 Modified factor X polypeptides and uses thereof |
| 01/30/2014 | US20140030246 Methods of treating kaposi's sarcoma |
| 01/30/2014 | US20140030244 Extracts isolated from electroporated ambhibian oocytes and use thereof in treating diseases and disorders |
| 01/30/2014 | US20140030240 Methods and compositions for modulating pd1 |
| 01/30/2014 | US20140030226 Prevention and treatment of ocular side effects with a cyclosporin |
| 01/30/2014 | US20140030221 Macrocyclic inhibitors of flaviviridae viruses |
| 01/30/2014 | US20140030217 Vaccine immunotherapy |
| 01/30/2014 | US20140030216 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors |
| 01/30/2014 | US20140030215 Macrophage Activating Factor For Pharmaceutical Compositions |
| 01/30/2014 | US20140030214 Liquid formulation of g-csf |
| 01/30/2014 | US20140030212 Compositions, methods and devices for activating an immune response |
| 01/30/2014 | US20140030211 Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof |
| 01/29/2014 | EP2689774A1 Reversely thermo-reversible hydrogel compositions |
| 01/29/2014 | EP2688908A1 Targeted cytokine for treatment of musculoskeletal diseases |
| 01/29/2014 | EP2688594A2 Methods and compositions for the treatment of cancer |
| 01/29/2014 | EP2688589A1 Method for the production of protein complexes and vaccine compositions comprising the same |
| 01/29/2014 | EP2688585A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins |
| 01/29/2014 | EP2688584A1 Pegylated human hdl particle and process for production thereof |
| 01/29/2014 | EP2688583A1 Protection against influenza infection by granulocyte-macrophage colony stimulating factor |
| 01/29/2014 | EP2688582A1 Neuroprotective peptides |
| 01/29/2014 | EP2688581A1 Immune suppressor and its use |
| 01/29/2014 | EP2688580A1 Vancomycin derivatives |
| 01/29/2014 | EP2688579A2 Aromatic-cationic peptides and uses of same |
| 01/29/2014 | EP2688578A2 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo |
| 01/29/2014 | EP2688572A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof. |
| 01/29/2014 | EP2688565A1 Treatment of proliferative disorders with a chemiluminescent agent |
| 01/29/2014 | EP2688563A1 Gallium complexes, pharmaceutical compositions and methods of use |
| 01/29/2014 | EP2548569B1 Stem cell derived paracrine factor h1 for use in reducing cell death in cardiac tissue |
| 01/29/2014 | EP2120991B1 Treatment of trauma hemorrhage with short oligopeptides |
| 01/29/2014 | EP2001903B1 Long-acting polypeptides and methods of producing and administering same |
| 01/29/2014 | EP1196638B1 Use of the krit1 gene in angiogenesis |
| 01/29/2014 | CN103547591A Growth hormone releasing factor (GRF) analogs and uses thereof |
| 01/29/2014 | CN103547287A Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 01/29/2014 | CN103547285A Immortalized avian cell lines and use thereof |
| 01/29/2014 | CN103547284A Immunity inducing agent |
| 01/29/2014 | CN103547282A Therapeutic agent for alopecia |
| 01/29/2014 | CN103547281A Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/29/2014 | CN103547280A Macrophage activating factor for pharmaceutical compositions |
| 01/29/2014 | CN103547279A Lyophilized preparation of cytotoxic dipeptides |
| 01/29/2014 | CN103547278A Immunity induction agent |
| 01/29/2014 | CN103540600A Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 01/29/2014 | CN103539862A Long-acting recombinant follicle-stimulating hormone and application thereof |
| 01/29/2014 | CN103539861A Long-acting recombinant human follicle-stimulating hormone-Fc fusion protein (hFSH-Fc) |
| 01/29/2014 | CN103539860A Long-acting recombinant human follicle-stimulating hormone-Fc fusion protein (hFSH-Fc) |
| 01/29/2014 | CN103539851A Generation of artificial binding proteins based on ubiquitin proteins |
| 01/29/2014 | CN103539850A Peptide separately separated from pig and use thereof |
| 01/29/2014 | CN103539849A Circular synthesized polypeptide D and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539848A Annular synthetic polypeptide A and application thereof in term of bacteria and virus resistance |
| 01/29/2014 | CN103539847A Cyclic synthetic peptide B, and antibacterial and antiviral application thereof |
| 01/29/2014 | CN103539846A Circular synthesized polypeptide F and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539845A Circular synthesized polypeptide E and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539844A Cyclic synthetic peptide C, and antibacterial and antiviral application thereof |
| 01/29/2014 | CN103539840A Epidermal growth factor receptor (EGFR) mimotope peptide and application thereof |
| 01/29/2014 | CN103539838A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl RGD peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539837A 1-methyl-beta-carbolinyl-3-formyl RGD peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539836A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl YIGS peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539835A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl YIGS peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539834A Chemerin derived peptide and expressed gene and application thereof |
| 01/29/2014 | CN103539833A High-activity alpha-glucosidase inhibitory peptide and preparation method and application thereof |
| 01/29/2014 | CN103539831A Prunus armeniaca alpha-glucosidase inhibiting peptide as well as preparation method and application of inhibiting peptide |
| 01/29/2014 | CN103536932A Use of SLC17A5 gene and coded protein thereof in preparing medicines for treating or diagnosing nitrate transfer or metabolic block or disorder related diseases |
| 01/29/2014 | CN103536917A Use of interferon in treatment of tumor, and related product and method |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 01/29/2014 | CN103536910A 细胞色素c注射液 Cytochrome c injection |
| 01/29/2014 | CN103536909A Novel urea nitrogen solid adsorption preparation and preparation method thereof |
| 01/29/2014 | CN103536908A Plant raw martial based medicine for preventing and treating reddish sudamen |
| 01/29/2014 | CN103536907A Application of liraglutide in preparation of drug for treating osteoporosis |
| 01/29/2014 | CN103536906A Use of pegylated Type III Interferons for the treatment of hepatitis C |
| 01/29/2014 | CN103536905A Application of interleukin-2 in preparation of medicament for treating psoriasis |
| 01/29/2014 | CN103536904A Application of metrn1 protein in aspect of preparation of hypoglycemic drug |
| 01/29/2014 | CN103536903A Application of metrn1 protein in aspect of preparation of lipid-lowering drug |
| 01/29/2014 | CN103536902A Application of recombinant protein of Lj-RGD3 full-RGD motif-deleted mutant Lj-112 in preparing antifungal drug |
| 01/29/2014 | CN103536901A Application of recombined ganoderma lucidum immunomodulatory protein in preparing drug for treating parkinsonism |
| 01/29/2014 | CN103536900A Erythrogenin mimetic peptide-containing pharmaceutical composition |
| 01/29/2014 | CN103536899A Application of active peptide compound in rhizoma sparganii |
| 01/29/2014 | CN103536898A Thymopentin (TP-5) drug composition |
| 01/29/2014 | CN103536897A Compound for inhibiting aggregation of amyloid polypeptide as well as preparation method and application thereof |
| 01/29/2014 | CN103536896A Enalapril composition freeze-dried powder for injection |
| 01/29/2014 | CN103536895A Bionic nano carrier system for protein drug delivery and preparation method |
| 01/29/2014 | CN103536567A Thymopentin (TP-5) powder injection |
| 01/29/2014 | CN103536525A Preparation method of intraocular controlled release agent of interleukin 18 |
| 01/29/2014 | CN103082276B Composition for reducing sport injury and promoting sport injury repair |